‘Aripiprazole’ schizophrenia market opens by its PMS expiration
The market of ‘aripiprazole’ drugs, schizophrenia treatments whose patent will be expired in PMS, will widely open on the coming 20th.
According to the Ministry of Food and Drug Safety, the number of products which are approved as single medicine of aripiprazole, is 58 products and has continuou...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
